Although many psychopharmacologic treatments and behavioral or cognitive behavioral interventions have been established as evidence-based practices, they have seldom been directly compared to one another as to outcome in children with emotional or behavioral disorders (EBD). In this paper, we present findings from 6 recent randomized clinical trials that made such direct comparisons. Three involve children with attention deficit hyperactivity disorder (ADHD), and 3 involve children or adolescents with depression or anxiety disorders. Findings suggest that combined treatments are probably most efficacious but that psychopharmacologic treatments may be somewhat more effective than behavioral or cognitive behavioral interventions in at least 5 of the 6 trials. These results are discussed in reference to pursuit of evidence-based practice in special education.
Get full access to this article
View all access options for this article.
References
1.
AbikoffH., HechtmanL., KleinR., GallagherR., FleissK., EtcovitchJ., CousinsL., GreenfieldB., MartinD., & PollackS. (2004). Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.Journal of the American Academy of Child and Adolescent Psychiatry, 43, 820–829.
2.
AbikoffH., HechtmanL., KleinR., WeissG., FleissK., EtcovitchJ., CousinsL., GreenfieldB., MartinD., & PollackS. (2004). Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.Journal of the American Academy of Child and Adolescent Psychiatry, 43, 802–811.
3.
AdamsG. B. (2004). Identifying, assessing and treating obsessive-compulsive disorder in school-aged children: The role of school personnel.Teaching Exceptional Children, 37, 46–53.
4.
AsarnowJ. R., JaycoxL. A., DuanN., LaBordA. P., ReaM. M., MurrayP., AndersonM., LandonC., TangL., & WellsK. B. (2005). Effectiveness of a quality improvement intervention for adolescent depression in primary care clinics: A randomized controlled trial.Journal of the American Medical Association, 293, 311–319.
5.
AsbahrF. R., CastilloA. R., ItoL. M., LaTorreM. D. R. D. D., MoreiraM. N., & Lotufo-NetoF. (2005). Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder.Journal of the American Academy of Child and Adolescent Psychiatry, 44, 1128–1136.
6.
BernsteinG. A., BorchardtC. M., PerwienA. R., CrosbyR. D., KushnerM. G., ThurasP. D., & LastC. G. (2000). Imipramine plus cognitive-behavioral therapy in the treatment of school refusal.Journal of the American Academy of Child and Adolescent Psychiatry, 39, 276–283.
7.
BernsteinG. A., LayneA. E., EganE. A., & TennisonD. M. (2005). School-based interventions for anxious children.Journal of the American Academy of Child and Adolescent Psychiatry, 44, 1118–1127.
8.
BussingR., ZimaB. T., MasonD., HouW. M., GarvanC. W., & FornessS. R. (2005). Use and persistence of pharmacotherapy for elementary school students with attention deficit hyperactivity disorder.Journal of Child and Adolescent Psychopharmacology, 15, 78–87.
9.
ChackoA., PelhamW. E.Jr., GnagyE. M., GreinerA., VallanoG., BuksteinO., & RancurelloM. (2005). Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder.Journal of the American Academy of Child and Adolescent Psychiatry, 44, 249–257.
10.
ChaitA., & JensenP. (2004–2005). Attention deficit hyperactivity disorder (ADHD).Emotional and Behavioral Disorders in Youth5, 3–5, 20–23.
11.
ChaitA., & PerkinsM. B. (2004–2005). Anxiety disorders.Emotional and Behavioral Disorders in Youth5, 6–8, 18–19.
12.
ClarkeG., DebarL., LynchF., PowellJ., GaleJ., O'ConnorE., LudmanE., BushT., LinE., VonKorffM., & HertetS. (2005). A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication.Journal of the American Academy of Child and Adolescent Psychiatry, 44, 888–898.
13.
ComptonS. N., MarchJ. S., BrentD., AlbanoA. M., WeersingV. R., & CurryJ. (2004). Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: An evidence-based review.Journal of the American Academy of Child and Adolescent Psychiatry, 43, 930–959.
14.
ConnersC. K., EpsteinJ. N., MarchJ. S., AngoldA., WellsK. C., KlaricJ., SwansonJ. M., ArnoldL. E., AbikoffH. B., ElliottG. R., GreenhillL. L., HechtmanL., HinshawS. P., HozaB., JensenP. S., KraemerH. C., NewcornJ. H., PelhamW. E., SevereJ. B., VitielloB., & WigalT. (2001). Multimodal treatment of ADHD in the MTA: An alternative outcome analysis.Journal of the American Academic of Child and Adolescent Psychiatry, 40, 159–167.
15.
CrenshawT. M., KavaleK. A., FornessS. R., & ReeveR. E. (1999). Attention deficit hyperactivity disorder and the efficacy of stimulation medication: A meta-analysis. In ScruggsT., & MastropieriM. (Eds.), Advances in learning and behavioral disabilities (Vol. 13, pp. 135–165). Greenwich, CT: JAI.
16.
deHaanE., HoogduinK. A., BuitelaarJ. K., & KeijsersG. P. (1998). Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents.Journal of the American Academy of Child and Adolescent Psychiatry, 37, 1022–1029.
17.
FornessS. R. (2003). Barriers to evidence-based treatment: Developmental psychopathology and the interdisciplinary disconnect in school mental health practice.Journal of School Psychology, 41, 61–67.
18.
FornessS. R. (2005). The pursuit of evidence-based practice in special education for children with emotional or behavioral disorders.Behavioral Disorders, 30, 311–330.
19.
FornessS. R., & KavaleK. A. (2001). Ignoring the odds: Hazards of not adding the medical model to special education decisions.Behavioral Disorders, 26, 269–281.
20.
FornessS. R., & KavaleK. A. (2002). Impact of ADHD on school systems. In JensenP. S., & CooperJ. R. (Eds.), Attention deficit hyperactivity disorder: State of the science; best practices (pp. 1–20). Kingston, NJ: Civic Research Institute.
21.
FornessS. R., KavaleK. A., & DavanzoP. A. (2002). The new medical model: Interdisciplinary treatment and the limits of behaviorism.Behavioral Disorders, 27, 168–178.
22.
FornessS. R., WalkerH. M., & KavaleK. A. (2003–2004). Psychiatric disorders and their treatment: A primer for school professionals.Report on Emotional and Behavioral Disorders of Youth4, 3–6, 20–23.
23.
GerberM. M., & SolariE. J. (2005). Teaching effort and the future of cognitive-behavioral interventions.Behavioral Disorders, 30, 289–299.
24.
GullyV., NorthupJ., HuppS., SperaS., LeVelleJ., & RidgwayA. (2003). Sequential evaluation of behavioral treatments and methylphenidate dosage for children with attention deficit hyperactivity disorder.Journal of Applied Behavioral Analysis, 36, 375–380.
25.
GussakiT., & PappadopulosE. (2004–2005). Child/adolescent schizophrenia.Emotional and Behavioral Disorders in Youth5, 12–15.
26.
HamiltonJ. D. (2005). Clinicians' guide to evidence-based practice.Journal of the American Academy of Child and Adolescent Psychiatry, 44, 494–498.
27.
HechtmanL., AbikoffH., KleinR. G., GreenfieldB., EtcovitchJ., CousinsL., FleissK., & WeissM. (2004). Children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment: Impact on parental practices.Journal of the American Academy of Child and Adolescent Psychiatry, 43, 830–838.
28.
HechtmanL., AbikoffH., KleinR. G., WeissG., RespitzC., KouriJ., BlumC., GreenfieldB., EtcovitchJ., FleissK., & PollackS. (2004). Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.Journal of the American Academy of Child and Adolescent Psychiatry, 43, 812–819.
29.
HinshawS. P. (2005). The stigmatization of mental illness in children and parents: developmental issues, family concerns, and research needs.Journal of Child Psychology and Psychiatry, 46, 714–734.
30.
HozaB., GerdesA. C., MrugS., HinshawS. P., BukowskiW. M., GoldJ. A., Arnold,L E., AbikoffH. B., ConnersC. K., ElliottG. R., Greenhill,L L., HechtmanL., JensenP. S., KraemerH. C., MarchJ. S., NewcornJ. H., SevereJ. B., SawnsonJ. M., VitielloB., WellsK. C., & WigalT. (2005). Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder.Journal of Clinical Child and Adolescent Psychology, 34, 74–86.
31.
InselT. R., & QuirionR. (2005). Psychiatry as a clinical neuroscience discipline.Journal of the American Medical Association, 294, 2221–2226.
32.
JaffeeS. R., HarringtonH., CohenP., & MoffittT. E. (2005). Editorial: Cumulative prevalence of psychiatric disorder in youths.Journal of the American Academy of Child and Adolescent Psychiatry, 44, 406–407.
33.
KleinR. G., AbikoffH., HechtmanL., & WeissG. (2004). Design and rationale of controlled study of long term methylphenidate and multimodal psychosocial treatment in children with ADHD.Journal of the American Academy of Child and Adolescent Psychiatry, 43, 792–801.
34.
KollinsS. H., BarkleyR. A., & DuPaulG. J. (2001). Use and management of medications for children diagnosed with attention deficit hyperacity disorder (ADHD).Focus on Exceptional Children, 33, 1–24.
35.
KonopasekD. E., & FornessS. (2004). Psychopharmacology in the treatment of emotional and behavioral disorders. In RutherfordR. B., QuinnM. M., & MathurS. R. (Eds.), Handbook of research in emotional and behavioral disorders (pp. 352–368). New York: Guilford.
36.
KravitzR. L., EpsteinR. M., FeldmanM. D., FranzC. E., AzariR., WilkesM. S., HintonL., & FranksP. (2005). Infl uence of patients' requests for direct-to-consumer advertised antidepressants: A randomized controlled trial.Journal of American Medical Association, 293, 1995–2002.
37.
KuehnB. M. (2005). Mental illness takes a heavy toll on youth.Journal of the American Medical Association, 294, 293–295.
38.
LeslieL. K., WeckerlyJ., PlemmonsD., LandsverkJ., & EastmanS. (2004). Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings.Pediatrics, 114, 129–140.
39.
LewisT. J., HudsonS., RichterM., & JohnsonN. (2004). Scientifically supported practices in emotional and behavioral disorders: A proposed approach and brief review of current practices.Behavioral Disorders, 29, 247–259.
40.
MayerM., LochmanJ., & Van AckerR. (2005). Introduction to the special issue: Cognitive-behavioral interventions with students with EBD.Behavioral Disorders, 30, 197–212.
41.
McClellanJ. M., & WerryJ. S. (2003). Evidence-based treatments in child and adolescent psychiatry: An inventory.Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1388–1400.
42.
MTA Cooperative Group. (1999a). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder.Archives of General Psychiatry, 56, 1073–1086.
43.
MTA Cooperative Group. (1999b). Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder.Archives of General Psychiatry, 56, 1088–1096.
44.
MTA Cooperative Group. (2004a). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24 month outcomes of treatment strategies for attention deficit hyperactivity disorder.Pediatrics, 113, 754–761.
45.
MTA Cooperative Group. (2004b). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment.Pediatrics, 113, 762–769.
46.
OdomS. L., BrantlingerE., GerstenR., HornerR. H., ThompsonB., & HarrisK. R. (2005). Research in special education: Scientific methods and evidence-based practices.Exceptional Children, 71, 137–148.
47.
OrtegaM. L., & JensenP. S. (2004–2005). Autism.Emotional and Behavioral Disorders in Youth5, 9–11, 23.
48.
Pediatric OCD Treatment Study Team. (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The pediatric OCD treatment study (POTS) randomized controlled trial.Journal of the American Medical Association, 292, 1969–1976.
49.
PelhamW. E. (1999). The NIMH Multimodal Treatment Study for attention deficit hyperactivity disorder: Just say yes to drugs alone?Canadian Journal of Psychiatry, 44, 981–990.
50.
PelhamW. E., GnagyE. M., ChronisA. M., Burrows-MacLeanL., FabianoG. A., OnyangoA. N., MeichenbaumD. L., WilliamsA., AronoffH. R., & SteinerR. L. (1999). A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention deficit hyperactivity disorder.Pediatrics, 104, 1300–1311.
51.
PelhamW. E., Burrows-MacleanL., GnagyE. M., FabianoG. A., ColesE. K., TrescoK. E., ChackoA., WymbsB. T., WienkeA. L., WalkerK. S., & HoffmanM. T. (2005). Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.Experimental Clinical Psychopharmacology, 13, 111–126.
52.
PierceC. D., ReidR., & EpsteinM. (2004). Teacher-mediated interventions for children with EBD and their academic outcomes: A review.Remedial and Special Education, 25, 175–188.
53.
PolsgroveL., & SmithS. W. (2004). Informed practice in teaching self-control to children with emotional and behavioral disorders. In RutherfordR. B., QuinnM. M., & MathurS. R. (Eds.), Handbook of research in emotional and behavioral disorders (pp. 399–425). New York: Guilford.
54.
RibaM. B., & BalonR. (2005). Competency in combining pharmacotherapy and psychotherapy: Integrated and split treatment core competencies in psychotherapy.Washington, DC: American Psychiatric Association.
55.
RingoldS. (2005). Antidepressant warning focuses attention on unmet need for child psychiatrists.Journal of the American Medical Association, 293, 537–538.
56.
RobertsR. E., AttkissonC. A., & RosenblattA. (1998). Prevalence of psychopathology among children and adolescents.American Journal of Psychiatry, 155, 715–725.
57.
RyanJ. B., ReidR., EpsteinM. H., EllisC., & EvansJ. H. (2005). Pharmacological intervention research for academic outcomes for students with ADHD.Behavioral Disorders, 30, 135–154.
58.
SchnoesC., ReidR., WagnerM., & MarderC. (in press). ADHD among students receiving special education services: A national survey.Exceptional Children.
59.
SpiraE. G., & FischelJ. E. (2005). The impact of preschool inattention, hyperactivity, and impulsivity on social and academic development: A review.Journal of Child and Adolescent Psychology and Psychiatry, 46, 755–773.
60.
SwansonJ. M., KraemerH. C., HinshawS. P., ArnoldL. E., ConnersC. K., AbikoffH. B., ClevengerW., DaviesM., ElliottG. R., GreenhillL. L., HechtmanL., HozaB., JensenP. S., MarchJ. S., NewcornJ. H., OwensE. B., PelhamW. E., SchillerE., SevereJ. B., SimpsonS., VitielloB., WellsK., WigalT., & WuM. (2001). Clinical relevance of the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment.Journal of the American Academy of Child and Adolescent Psychiatry, 40, 168–179.
61.
Treatment for Adolescents with Depression Study Team. (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depressions Study (TADS) randomized controlled trial.Journal of the American Medical Association, 292, 807–820.
62.
VarleyC. K. (2004). Drugs and depression: A review of Let them eat Prozac: The unhealthy relationship between the pharmaceutical industry and depression.Journal of the American Medical Association, 292, 2920–2921.
63.
WalkerH. M., RamseyE., & GreshamF. M. (2004). Antisocial behavior in school: Evidence-based practices (2nd ed.). Belmont, CA: Wadsworth/Thomson Learning.
64.
WalterH. J., & BerkovitzI. H. (2005). Practice parameter for psychiatric consultation to schools.Journal of the American Academy of Child and Adolescent Psychiatry, 44, 1068–1084.
65.
WhalenC. K. (2001). ADHD treatment in the 21st century: Pushing the envelope.Journal of Clinical Child Psychology, 30, 136–140.
66.
WilensT. E. (2001). Straight talk about psychiatric medications for kids.New York: Guilford.
67.
WilliamsJ., KlinepeterK., PalmesG., PulleyA., & Meschan FoyJ. (2004). Diagnosis and treatment of behavioral health disorders in pediatric practice.Pediatrics, 114, 601–606.
68.
ZarkiskiA. L., WheelerE., BurdaJ., & ShieldsA. (2005). Justifiable psychopharmacology or overzealous prescription? Examining parental reports of the lifetime prescription histories of psychiatrically hospitalized children.Child and Adolescent Mental Health, 10, 16–22.
69.
ZimaB. T., HurlburtM. S., KnappP., LaddH., & TangL. (2005). Quality of publicly-funded outpatient specialty mental health care for common childhood psychiatric disorders in California.Journal of the American Academy of Child and Adolescent Psychiatry, 44, 130–144.
70.
ZitoJ. M., & SaferD. J. (2005). Recent child pharmacoepidemiological findings.Journal of Child and Adolescent Psychopharmacology, 15, 5–9.
